Evidence map›Paper›PMID 39891186›Full record

ArticleCancer imaging : the official publication of the International Cancer Imaging Society2025

Survival outcome prediction of esophageal squamous cell carcinoma patients based on radiomics and mutation signature.

Ting Yan, Zhenpeng Yan, Guohui Chen, Songrui Xu, Chenxuan Wu, Qichao Zhou, Guolan Wang, Ying Li, Mengjiu Jia, Xiaofei Zhuang and 6 more

Abstract read
In one paragraph

Article in Cancer imaging : the official publication of the International Cancer Imaging Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Ting YanSecond Clinical Medical College, Shanxi Medical University, Taiyuan, Shanxi, 030001, People's Republic of China.
Zhenpeng YanTranslational Medicine Research Center, Shanxi Medical University, Taiyuan, Shanxi, 030001, People's Republic of China.
Guohui ChenTranslational Medicine Research Center, Shanxi Medical University, Taiyuan, Shanxi, 030001, People's Republic of China.
Songrui XuTranslational Medicine Research Center, Shanxi Medical University, Taiyuan, Shanxi, 030001, People's Republic of China.
Chenxuan WuSchool of Life Science, Beijing Institute of Technology, Beijing, People's Republic of China.
Qichao ZhouTranslational Medicine Research Center, Shanxi Medical University, Taiyuan, Shanxi, 030001, People's Republic of China.
Guolan WangSchool of Computer Information Engineering, Shanxi Technology and Business University, Taiyuan, Shanxi, 030006, People's Republic of China.
Ying LiCollege of Information and Computer, Taiyuan University of Technology, Taiyuan, Shanxi, 030024, People's Republic of China.
Mengjiu JiaSchool of Computer Information Engineering, Shanxi Technology and Business University, Taiyuan, Shanxi, 030006, People's Republic of China.
Xiaofei ZhuangDepartment of Thoracic Surgery, Shanxi Cancer Hospital, Taiyuan, Shanxi, 030013, People's Republic of China.
Jie YangDepartment of Gastroenterology, Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, 030001, People's Republic of China.
Lili LiuTranslational Medicine Research Center, Shanxi Medical University, Taiyuan, Shanxi, 030001, People's Republic of China.
Lu WangTranslational Medicine Research Center, Shanxi Medical University, Taiyuan, Shanxi, 030001, People's Republic of China.
Qinglu WuTranslational Medicine Research Center, Shanxi Medical University, Taiyuan, Shanxi, 030001, People's Republic of China.
Bin WangCollege of Information and Computer, Taiyuan University of Technology, Taiyuan, Shanxi, 030024, People's Republic of China. wangbin01@tyut.edu.cn.
Tianyi YanSchool of Life Science, Beijing Institute of Technology, Beijing, People's Republic of China. yantianyi@bit.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe present study aimed to develop a nomogram model for predicting overall survival (OS) in esophageal squamous cell carcinoma (ESCC) patients.

methodsA total of 205 patients with ESCC were enrolled and randomly divided into a training cohort (n = 153) and a test cohort (n = 52) at a ratio of 7:3. Multivariate Cox regression was used to construct the radiomics model based on CT data. The mutation signature was constructed based on whole genome sequencing data and found to be significantly associated with the prognosis of patients with ESCC. A nomogram model combining the Rad-score and mutation signature was constructed. An integrated nomogram model combining the Rad-score, mutation signature, and clinical factors was constructed.

resultsA total of 8 CT features were selected for multivariate Cox regression analysis to determine whether the Rad-score was significantly correlated with OS. The area under the curve (AUC) of the radiomics model was 0.834 (95% CI, 0.767-0.900) for the training cohort and 0.733 (95% CI, 0.574-0.892) for the test cohort. The Rad-score, S3, and S6 were used to construct an integrated RM nomogram. The predictive performance of the RM nomogram model was better than that of the radiomics model, with an AUC of 0. 830 (95% CI, 0.761-0.899) in the training cohort and 0.793 (95% CI, 0.653-0.934) in the test cohort. The Rad-score, TNM stage, lymph node metastasis status, S3, and S6 were used to construct an integrated RMC nomogram. The predictive performance of the RMC nomogram model was better than that of the radiomics model and RM nomogram model, with an AUC of 0. 862 (95% CI, 0.795-0.928) in the training cohort and 0. 837 (95% CI, 0.705-0.969) in the test cohort.

conclusionAn integrated nomogram model combining the Rad-score, mutation signature, and clinical factors can better predict the prognosis of patients with ESCC.

Indexed as

Esophageal NeoplasmsEsophageal Squamous Cell CarcinomaNomogramsTomography, X-Ray ComputedAdultAgedFemaleHumansMaleMiddle AgedMutationPrognosisRadiomicsEsophageal squamous cell carcinomaMutation signatureNomogramPrognosisRadiomics

Identifiers

PMID39891186
PMCPMC11783911

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.